CELL DEATH DISCOV 润色咨询

Cell Death Discovery

出版年份:暂无数据 年文章数:928 投稿命中率: 开通期刊会员,数据随心看

出版周期:暂无数据 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运,编辑和审稿人一生平安!!!<br><br>Manuscript Under Consideration 11th Apr 24 05:59:46<br>Editor Assigned 10th Apr 24 04:50:35<br>Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=昨天, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2167353, encodeId=b340216e35352, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经系统凋亡及机制<br>经验分享:更新一下投稿时间线:<br>Manuscript Received: 7.3<br>Editor Assigned :7.3<br>Manuscript Under Consideration: 7.4<br>Manuscript Under Consideration: 8.31<br>Decision Made: 9.2<br>Decision Sent to Author: 9.8 (一审65天,等的急啊;要求11.1前返回)<br>Manuscript Received: 10.18<br>Editor Assigned: 10.18<br>Manuscript Under Consideration: 10.19<br>目前返回20天了,research square状态还是 Submission checks complete,编辑还没有返回审稿人手里,要怎么办呀?要催吗?二审一般多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=58, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daea8237862, createdName=ms6000000748440029, createdTime=Wed Nov 08 10:04:15 CST 2023, time=2023-11-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2100036, encodeId=1276210003694, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:请问大家,Decision sent back to author后底部有一个<br>There are action items pending. Please click on the links next to the arrows .<br>Manuscript Tasks<br> Request Appeal<br> Check Status<br>这是什么意思,通讯作者也没有收到邮件,是拒稿了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3a515544947, createdName=ms3000001031683106, createdTime=Sat Nov 12 10:28:29 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0<br>经验分享:under consideration80天了,谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157541, encodeId=1ccd215e54134, content=偏重的研究方向:细胞死亡<br>经验分享:之前投小CDD送审后被拒建议转投小小CDD。半个月后编辑将之前的审稿意见再次返回来,建议根据审稿意见修改。因为上次有一份审稿意见并不是很理想加上面临毕业,所以比较担心。有没有相同经历的朋友可以分享一下经验呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fda95570287, createdName=MM---, createdTime=Wed Sep 13 16:40:57 CST 2023, time=2023-09-13, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2192675, encodeId=d23d21926e582, content=审稿速度:12.0<br>经验分享:2023年7月投稿<br>一审73天<br>二审(包含元旦)73天<br>临时接收到正式接收 29天<br><br>可以说很慢了,急着毕业不推荐<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e592182462, createdName=12077503m07(暂无昵称), createdTime=Tue Mar 12 01:03:15 CST 2024, time=2024-03-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185091, encodeId=6ca521850918c, content=审稿速度:1.0<br>经验分享:一篇综述原则性接收了 总体来说挺快的 23.10.23 提交 23.10.24 第一次under consideration 23.11.13 第二次under consideration 23.11.18 Decision Made 23.11.20 send author 24.1.14 修回 24.1.15 第一次under consideration 24.1.15 第二次under consideration 24.1.26 Decision Made 24.1.30 原则性接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Wed Jan 31 20:04:17 CST 2024, time=2024-01-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2150842, encodeId=10cf215084251, content=审稿速度:1.0<br>偏重的研究方向:非编码RNA与肿瘤<br>经验分享:投了小cdd一个月送审返回意见后被拒,自行补了一部分实验后转投这里 6.5 投稿 6.19 小修 7.13 补了实验返回去 7.18 原则性接收 7.20 改好格式返回 7.26 接收 7.28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2598527487, createdName=Terryzhong15, createdTime=Tue Aug 01 23:23:27 CST 2023, time=2023-08-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:Cddise转投过来的,9天decision made,不知道是什么结果,这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188846, encodeId=a2db21888463f, content=2月5号投的,当天分配编辑并Under Consideration,现在投稿17天了还没有消息,大家最近都是多久送审或者被拒的呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLv3zmjYMzwQhcQkUYuJuQtVn1K9UfSHicAAqich642LF9jozKbFliaZw0tGbw3kSTrABiaD0O5JDHXXQ/132, createdBy=215e5309360, createdName=legendaryCYP, createdTime=Fri Feb 23 10:37:35 CST 2024, time=2024-02-23, status=1, ipAttribution=上海)]
    昨天 白衣13 来自伊利诺伊

    求好运,编辑和审稿人一生平安!!!

    Manuscript Under Consideration 11th Apr 24 05:59:46
    Editor Assigned 10th Apr 24 04:50:35
    Manuscript Received 10th Apr 24 04:50:34

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运,编辑和审稿人一生平安!!!<br><br>Manuscript Under Consideration 11th Apr 24 05:59:46<br>Editor Assigned 10th Apr 24 04:50:35<br>Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=昨天, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2167353, encodeId=b340216e35352, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经系统凋亡及机制<br>经验分享:更新一下投稿时间线:<br>Manuscript Received: 7.3<br>Editor Assigned :7.3<br>Manuscript Under Consideration: 7.4<br>Manuscript Under Consideration: 8.31<br>Decision Made: 9.2<br>Decision Sent to Author: 9.8 (一审65天,等的急啊;要求11.1前返回)<br>Manuscript Received: 10.18<br>Editor Assigned: 10.18<br>Manuscript Under Consideration: 10.19<br>目前返回20天了,research square状态还是 Submission checks complete,编辑还没有返回审稿人手里,要怎么办呀?要催吗?二审一般多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=58, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daea8237862, createdName=ms6000000748440029, createdTime=Wed Nov 08 10:04:15 CST 2023, time=2023-11-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2100036, encodeId=1276210003694, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:请问大家,Decision sent back to author后底部有一个<br>There are action items pending. Please click on the links next to the arrows .<br>Manuscript Tasks<br> Request Appeal<br> Check Status<br>这是什么意思,通讯作者也没有收到邮件,是拒稿了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3a515544947, createdName=ms3000001031683106, createdTime=Sat Nov 12 10:28:29 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0<br>经验分享:under consideration80天了,谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157541, encodeId=1ccd215e54134, content=偏重的研究方向:细胞死亡<br>经验分享:之前投小CDD送审后被拒建议转投小小CDD。半个月后编辑将之前的审稿意见再次返回来,建议根据审稿意见修改。因为上次有一份审稿意见并不是很理想加上面临毕业,所以比较担心。有没有相同经历的朋友可以分享一下经验呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fda95570287, createdName=MM---, createdTime=Wed Sep 13 16:40:57 CST 2023, time=2023-09-13, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2192675, encodeId=d23d21926e582, content=审稿速度:12.0<br>经验分享:2023年7月投稿<br>一审73天<br>二审(包含元旦)73天<br>临时接收到正式接收 29天<br><br>可以说很慢了,急着毕业不推荐<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e592182462, createdName=12077503m07(暂无昵称), createdTime=Tue Mar 12 01:03:15 CST 2024, time=2024-03-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185091, encodeId=6ca521850918c, content=审稿速度:1.0<br>经验分享:一篇综述原则性接收了 总体来说挺快的 23.10.23 提交 23.10.24 第一次under consideration 23.11.13 第二次under consideration 23.11.18 Decision Made 23.11.20 send author 24.1.14 修回 24.1.15 第一次under consideration 24.1.15 第二次under consideration 24.1.26 Decision Made 24.1.30 原则性接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Wed Jan 31 20:04:17 CST 2024, time=2024-01-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2150842, encodeId=10cf215084251, content=审稿速度:1.0<br>偏重的研究方向:非编码RNA与肿瘤<br>经验分享:投了小cdd一个月送审返回意见后被拒,自行补了一部分实验后转投这里 6.5 投稿 6.19 小修 7.13 补了实验返回去 7.18 原则性接收 7.20 改好格式返回 7.26 接收 7.28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2598527487, createdName=Terryzhong15, createdTime=Tue Aug 01 23:23:27 CST 2023, time=2023-08-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:Cddise转投过来的,9天decision made,不知道是什么结果,这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188846, encodeId=a2db21888463f, content=2月5号投的,当天分配编辑并Under Consideration,现在投稿17天了还没有消息,大家最近都是多久送审或者被拒的呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLv3zmjYMzwQhcQkUYuJuQtVn1K9UfSHicAAqich642LF9jozKbFliaZw0tGbw3kSTrABiaD0O5JDHXXQ/132, createdBy=215e5309360, createdName=legendaryCYP, createdTime=Fri Feb 23 10:37:35 CST 2024, time=2024-02-23, status=1, ipAttribution=上海)]
    2023-11-08 ms6000000748440029 来自广东省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:神经系统凋亡及机制
    经验分享:更新一下投稿时间线:
    Manuscript Received: 7.3
    Editor Assigned :7.3
    Manuscript Under Consideration: 7.4
    Manuscript Under Consideration: 8.31
    Decision Made: 9.2
    Decision Sent to Author: 9.8 (一审65天,等的急啊;要求11.1前返回)
    Manuscript Received: 10.18
    Editor Assigned: 10.18
    Manuscript Under Consideration: 10.19
    目前返回20天了,research square状态还是 Submission checks complete,编辑还没有返回审稿人手里,要怎么办呀?要催吗?二审一般多久呀?

    58

    展开58条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运,编辑和审稿人一生平安!!!<br><br>Manuscript Under Consideration 11th Apr 24 05:59:46<br>Editor Assigned 10th Apr 24 04:50:35<br>Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=昨天, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2167353, encodeId=b340216e35352, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经系统凋亡及机制<br>经验分享:更新一下投稿时间线:<br>Manuscript Received: 7.3<br>Editor Assigned :7.3<br>Manuscript Under Consideration: 7.4<br>Manuscript Under Consideration: 8.31<br>Decision Made: 9.2<br>Decision Sent to Author: 9.8 (一审65天,等的急啊;要求11.1前返回)<br>Manuscript Received: 10.18<br>Editor Assigned: 10.18<br>Manuscript Under Consideration: 10.19<br>目前返回20天了,research square状态还是 Submission checks complete,编辑还没有返回审稿人手里,要怎么办呀?要催吗?二审一般多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=58, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daea8237862, createdName=ms6000000748440029, createdTime=Wed Nov 08 10:04:15 CST 2023, time=2023-11-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2100036, encodeId=1276210003694, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:请问大家,Decision sent back to author后底部有一个<br>There are action items pending. Please click on the links next to the arrows .<br>Manuscript Tasks<br> Request Appeal<br> Check Status<br>这是什么意思,通讯作者也没有收到邮件,是拒稿了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3a515544947, createdName=ms3000001031683106, createdTime=Sat Nov 12 10:28:29 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0<br>经验分享:under consideration80天了,谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157541, encodeId=1ccd215e54134, content=偏重的研究方向:细胞死亡<br>经验分享:之前投小CDD送审后被拒建议转投小小CDD。半个月后编辑将之前的审稿意见再次返回来,建议根据审稿意见修改。因为上次有一份审稿意见并不是很理想加上面临毕业,所以比较担心。有没有相同经历的朋友可以分享一下经验呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fda95570287, createdName=MM---, createdTime=Wed Sep 13 16:40:57 CST 2023, time=2023-09-13, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2192675, encodeId=d23d21926e582, content=审稿速度:12.0<br>经验分享:2023年7月投稿<br>一审73天<br>二审(包含元旦)73天<br>临时接收到正式接收 29天<br><br>可以说很慢了,急着毕业不推荐<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e592182462, createdName=12077503m07(暂无昵称), createdTime=Tue Mar 12 01:03:15 CST 2024, time=2024-03-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185091, encodeId=6ca521850918c, content=审稿速度:1.0<br>经验分享:一篇综述原则性接收了 总体来说挺快的 23.10.23 提交 23.10.24 第一次under consideration 23.11.13 第二次under consideration 23.11.18 Decision Made 23.11.20 send author 24.1.14 修回 24.1.15 第一次under consideration 24.1.15 第二次under consideration 24.1.26 Decision Made 24.1.30 原则性接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Wed Jan 31 20:04:17 CST 2024, time=2024-01-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2150842, encodeId=10cf215084251, content=审稿速度:1.0<br>偏重的研究方向:非编码RNA与肿瘤<br>经验分享:投了小cdd一个月送审返回意见后被拒,自行补了一部分实验后转投这里 6.5 投稿 6.19 小修 7.13 补了实验返回去 7.18 原则性接收 7.20 改好格式返回 7.26 接收 7.28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2598527487, createdName=Terryzhong15, createdTime=Tue Aug 01 23:23:27 CST 2023, time=2023-08-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:Cddise转投过来的,9天decision made,不知道是什么结果,这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188846, encodeId=a2db21888463f, content=2月5号投的,当天分配编辑并Under Consideration,现在投稿17天了还没有消息,大家最近都是多久送审或者被拒的呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLv3zmjYMzwQhcQkUYuJuQtVn1K9UfSHicAAqich642LF9jozKbFliaZw0tGbw3kSTrABiaD0O5JDHXXQ/132, createdBy=215e5309360, createdName=legendaryCYP, createdTime=Fri Feb 23 10:37:35 CST 2024, time=2024-02-23, status=1, ipAttribution=上海)]
    2022-11-12 ms3000001031683106

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享:请问大家,Decision sent back to author后底部有一个
    There are action items pending. Please click on the links next to the arrows .
    Manuscript Tasks
    Request Appeal
    Check Status
    这是什么意思,通讯作者也没有收到邮件,是拒稿了吗?

    5

    展开5条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运,编辑和审稿人一生平安!!!<br><br>Manuscript Under Consideration 11th Apr 24 05:59:46<br>Editor Assigned 10th Apr 24 04:50:35<br>Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=昨天, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2167353, encodeId=b340216e35352, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经系统凋亡及机制<br>经验分享:更新一下投稿时间线:<br>Manuscript Received: 7.3<br>Editor Assigned :7.3<br>Manuscript Under Consideration: 7.4<br>Manuscript Under Consideration: 8.31<br>Decision Made: 9.2<br>Decision Sent to Author: 9.8 (一审65天,等的急啊;要求11.1前返回)<br>Manuscript Received: 10.18<br>Editor Assigned: 10.18<br>Manuscript Under Consideration: 10.19<br>目前返回20天了,research square状态还是 Submission checks complete,编辑还没有返回审稿人手里,要怎么办呀?要催吗?二审一般多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=58, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daea8237862, createdName=ms6000000748440029, createdTime=Wed Nov 08 10:04:15 CST 2023, time=2023-11-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2100036, encodeId=1276210003694, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:请问大家,Decision sent back to author后底部有一个<br>There are action items pending. Please click on the links next to the arrows .<br>Manuscript Tasks<br> Request Appeal<br> Check Status<br>这是什么意思,通讯作者也没有收到邮件,是拒稿了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3a515544947, createdName=ms3000001031683106, createdTime=Sat Nov 12 10:28:29 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0<br>经验分享:under consideration80天了,谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157541, encodeId=1ccd215e54134, content=偏重的研究方向:细胞死亡<br>经验分享:之前投小CDD送审后被拒建议转投小小CDD。半个月后编辑将之前的审稿意见再次返回来,建议根据审稿意见修改。因为上次有一份审稿意见并不是很理想加上面临毕业,所以比较担心。有没有相同经历的朋友可以分享一下经验呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fda95570287, createdName=MM---, createdTime=Wed Sep 13 16:40:57 CST 2023, time=2023-09-13, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2192675, encodeId=d23d21926e582, content=审稿速度:12.0<br>经验分享:2023年7月投稿<br>一审73天<br>二审(包含元旦)73天<br>临时接收到正式接收 29天<br><br>可以说很慢了,急着毕业不推荐<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e592182462, createdName=12077503m07(暂无昵称), createdTime=Tue Mar 12 01:03:15 CST 2024, time=2024-03-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185091, encodeId=6ca521850918c, content=审稿速度:1.0<br>经验分享:一篇综述原则性接收了 总体来说挺快的 23.10.23 提交 23.10.24 第一次under consideration 23.11.13 第二次under consideration 23.11.18 Decision Made 23.11.20 send author 24.1.14 修回 24.1.15 第一次under consideration 24.1.15 第二次under consideration 24.1.26 Decision Made 24.1.30 原则性接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Wed Jan 31 20:04:17 CST 2024, time=2024-01-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2150842, encodeId=10cf215084251, content=审稿速度:1.0<br>偏重的研究方向:非编码RNA与肿瘤<br>经验分享:投了小cdd一个月送审返回意见后被拒,自行补了一部分实验后转投这里 6.5 投稿 6.19 小修 7.13 补了实验返回去 7.18 原则性接收 7.20 改好格式返回 7.26 接收 7.28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2598527487, createdName=Terryzhong15, createdTime=Tue Aug 01 23:23:27 CST 2023, time=2023-08-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:Cddise转投过来的,9天decision made,不知道是什么结果,这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188846, encodeId=a2db21888463f, content=2月5号投的,当天分配编辑并Under Consideration,现在投稿17天了还没有消息,大家最近都是多久送审或者被拒的呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLv3zmjYMzwQhcQkUYuJuQtVn1K9UfSHicAAqich642LF9jozKbFliaZw0tGbw3kSTrABiaD0O5JDHXXQ/132, createdBy=215e5309360, createdName=legendaryCYP, createdTime=Fri Feb 23 10:37:35 CST 2024, time=2024-02-23, status=1, ipAttribution=上海)]
    2022-08-19 121c6f2dm84(暂无昵称)

    审稿速度:6.0
    经验分享:under consideration80天了,谁说这个快来着。。

    13

    展开13条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运,编辑和审稿人一生平安!!!<br><br>Manuscript Under Consideration 11th Apr 24 05:59:46<br>Editor Assigned 10th Apr 24 04:50:35<br>Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=昨天, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2167353, encodeId=b340216e35352, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经系统凋亡及机制<br>经验分享:更新一下投稿时间线:<br>Manuscript Received: 7.3<br>Editor Assigned :7.3<br>Manuscript Under Consideration: 7.4<br>Manuscript Under Consideration: 8.31<br>Decision Made: 9.2<br>Decision Sent to Author: 9.8 (一审65天,等的急啊;要求11.1前返回)<br>Manuscript Received: 10.18<br>Editor Assigned: 10.18<br>Manuscript Under Consideration: 10.19<br>目前返回20天了,research square状态还是 Submission checks complete,编辑还没有返回审稿人手里,要怎么办呀?要催吗?二审一般多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=58, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daea8237862, createdName=ms6000000748440029, createdTime=Wed Nov 08 10:04:15 CST 2023, time=2023-11-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2100036, encodeId=1276210003694, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:请问大家,Decision sent back to author后底部有一个<br>There are action items pending. Please click on the links next to the arrows .<br>Manuscript Tasks<br> Request Appeal<br> Check Status<br>这是什么意思,通讯作者也没有收到邮件,是拒稿了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3a515544947, createdName=ms3000001031683106, createdTime=Sat Nov 12 10:28:29 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0<br>经验分享:under consideration80天了,谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157541, encodeId=1ccd215e54134, content=偏重的研究方向:细胞死亡<br>经验分享:之前投小CDD送审后被拒建议转投小小CDD。半个月后编辑将之前的审稿意见再次返回来,建议根据审稿意见修改。因为上次有一份审稿意见并不是很理想加上面临毕业,所以比较担心。有没有相同经历的朋友可以分享一下经验呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fda95570287, createdName=MM---, createdTime=Wed Sep 13 16:40:57 CST 2023, time=2023-09-13, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2192675, encodeId=d23d21926e582, content=审稿速度:12.0<br>经验分享:2023年7月投稿<br>一审73天<br>二审(包含元旦)73天<br>临时接收到正式接收 29天<br><br>可以说很慢了,急着毕业不推荐<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e592182462, createdName=12077503m07(暂无昵称), createdTime=Tue Mar 12 01:03:15 CST 2024, time=2024-03-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185091, encodeId=6ca521850918c, content=审稿速度:1.0<br>经验分享:一篇综述原则性接收了 总体来说挺快的 23.10.23 提交 23.10.24 第一次under consideration 23.11.13 第二次under consideration 23.11.18 Decision Made 23.11.20 send author 24.1.14 修回 24.1.15 第一次under consideration 24.1.15 第二次under consideration 24.1.26 Decision Made 24.1.30 原则性接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Wed Jan 31 20:04:17 CST 2024, time=2024-01-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2150842, encodeId=10cf215084251, content=审稿速度:1.0<br>偏重的研究方向:非编码RNA与肿瘤<br>经验分享:投了小cdd一个月送审返回意见后被拒,自行补了一部分实验后转投这里 6.5 投稿 6.19 小修 7.13 补了实验返回去 7.18 原则性接收 7.20 改好格式返回 7.26 接收 7.28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2598527487, createdName=Terryzhong15, createdTime=Tue Aug 01 23:23:27 CST 2023, time=2023-08-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:Cddise转投过来的,9天decision made,不知道是什么结果,这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188846, encodeId=a2db21888463f, content=2月5号投的,当天分配编辑并Under Consideration,现在投稿17天了还没有消息,大家最近都是多久送审或者被拒的呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLv3zmjYMzwQhcQkUYuJuQtVn1K9UfSHicAAqich642LF9jozKbFliaZw0tGbw3kSTrABiaD0O5JDHXXQ/132, createdBy=215e5309360, createdName=legendaryCYP, createdTime=Fri Feb 23 10:37:35 CST 2024, time=2024-02-23, status=1, ipAttribution=上海)]
    2023-09-13 MM--- 来自宁夏

    偏重的研究方向:细胞死亡
    经验分享:之前投小CDD送审后被拒建议转投小小CDD。半个月后编辑将之前的审稿意见再次返回来,建议根据审稿意见修改。因为上次有一份审稿意见并不是很理想加上面临毕业,所以比较担心。有没有相同经历的朋友可以分享一下经验呀?

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运,编辑和审稿人一生平安!!!<br><br>Manuscript Under Consideration 11th Apr 24 05:59:46<br>Editor Assigned 10th Apr 24 04:50:35<br>Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=昨天, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2167353, encodeId=b340216e35352, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经系统凋亡及机制<br>经验分享:更新一下投稿时间线:<br>Manuscript Received: 7.3<br>Editor Assigned :7.3<br>Manuscript Under Consideration: 7.4<br>Manuscript Under Consideration: 8.31<br>Decision Made: 9.2<br>Decision Sent to Author: 9.8 (一审65天,等的急啊;要求11.1前返回)<br>Manuscript Received: 10.18<br>Editor Assigned: 10.18<br>Manuscript Under Consideration: 10.19<br>目前返回20天了,research square状态还是 Submission checks complete,编辑还没有返回审稿人手里,要怎么办呀?要催吗?二审一般多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=58, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daea8237862, createdName=ms6000000748440029, createdTime=Wed Nov 08 10:04:15 CST 2023, time=2023-11-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2100036, encodeId=1276210003694, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:请问大家,Decision sent back to author后底部有一个<br>There are action items pending. Please click on the links next to the arrows .<br>Manuscript Tasks<br> Request Appeal<br> Check Status<br>这是什么意思,通讯作者也没有收到邮件,是拒稿了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3a515544947, createdName=ms3000001031683106, createdTime=Sat Nov 12 10:28:29 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0<br>经验分享:under consideration80天了,谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157541, encodeId=1ccd215e54134, content=偏重的研究方向:细胞死亡<br>经验分享:之前投小CDD送审后被拒建议转投小小CDD。半个月后编辑将之前的审稿意见再次返回来,建议根据审稿意见修改。因为上次有一份审稿意见并不是很理想加上面临毕业,所以比较担心。有没有相同经历的朋友可以分享一下经验呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fda95570287, createdName=MM---, createdTime=Wed Sep 13 16:40:57 CST 2023, time=2023-09-13, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2192675, encodeId=d23d21926e582, content=审稿速度:12.0<br>经验分享:2023年7月投稿<br>一审73天<br>二审(包含元旦)73天<br>临时接收到正式接收 29天<br><br>可以说很慢了,急着毕业不推荐<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e592182462, createdName=12077503m07(暂无昵称), createdTime=Tue Mar 12 01:03:15 CST 2024, time=2024-03-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185091, encodeId=6ca521850918c, content=审稿速度:1.0<br>经验分享:一篇综述原则性接收了 总体来说挺快的 23.10.23 提交 23.10.24 第一次under consideration 23.11.13 第二次under consideration 23.11.18 Decision Made 23.11.20 send author 24.1.14 修回 24.1.15 第一次under consideration 24.1.15 第二次under consideration 24.1.26 Decision Made 24.1.30 原则性接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Wed Jan 31 20:04:17 CST 2024, time=2024-01-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2150842, encodeId=10cf215084251, content=审稿速度:1.0<br>偏重的研究方向:非编码RNA与肿瘤<br>经验分享:投了小cdd一个月送审返回意见后被拒,自行补了一部分实验后转投这里 6.5 投稿 6.19 小修 7.13 补了实验返回去 7.18 原则性接收 7.20 改好格式返回 7.26 接收 7.28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2598527487, createdName=Terryzhong15, createdTime=Tue Aug 01 23:23:27 CST 2023, time=2023-08-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:Cddise转投过来的,9天decision made,不知道是什么结果,这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188846, encodeId=a2db21888463f, content=2月5号投的,当天分配编辑并Under Consideration,现在投稿17天了还没有消息,大家最近都是多久送审或者被拒的呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLv3zmjYMzwQhcQkUYuJuQtVn1K9UfSHicAAqich642LF9jozKbFliaZw0tGbw3kSTrABiaD0O5JDHXXQ/132, createdBy=215e5309360, createdName=legendaryCYP, createdTime=Fri Feb 23 10:37:35 CST 2024, time=2024-02-23, status=1, ipAttribution=上海)]
    2024-03-12 12077503m07(暂无昵称) 来自湖北省

    审稿速度:12.0
    经验分享:2023年7月投稿
    一审73天
    二审(包含元旦)73天
    临时接收到正式接收 29天

    可以说很慢了,急着毕业不推荐

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运,编辑和审稿人一生平安!!!<br><br>Manuscript Under Consideration 11th Apr 24 05:59:46<br>Editor Assigned 10th Apr 24 04:50:35<br>Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=昨天, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2167353, encodeId=b340216e35352, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经系统凋亡及机制<br>经验分享:更新一下投稿时间线:<br>Manuscript Received: 7.3<br>Editor Assigned :7.3<br>Manuscript Under Consideration: 7.4<br>Manuscript Under Consideration: 8.31<br>Decision Made: 9.2<br>Decision Sent to Author: 9.8 (一审65天,等的急啊;要求11.1前返回)<br>Manuscript Received: 10.18<br>Editor Assigned: 10.18<br>Manuscript Under Consideration: 10.19<br>目前返回20天了,research square状态还是 Submission checks complete,编辑还没有返回审稿人手里,要怎么办呀?要催吗?二审一般多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=58, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daea8237862, createdName=ms6000000748440029, createdTime=Wed Nov 08 10:04:15 CST 2023, time=2023-11-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2100036, encodeId=1276210003694, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:请问大家,Decision sent back to author后底部有一个<br>There are action items pending. Please click on the links next to the arrows .<br>Manuscript Tasks<br> Request Appeal<br> Check Status<br>这是什么意思,通讯作者也没有收到邮件,是拒稿了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3a515544947, createdName=ms3000001031683106, createdTime=Sat Nov 12 10:28:29 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0<br>经验分享:under consideration80天了,谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157541, encodeId=1ccd215e54134, content=偏重的研究方向:细胞死亡<br>经验分享:之前投小CDD送审后被拒建议转投小小CDD。半个月后编辑将之前的审稿意见再次返回来,建议根据审稿意见修改。因为上次有一份审稿意见并不是很理想加上面临毕业,所以比较担心。有没有相同经历的朋友可以分享一下经验呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fda95570287, createdName=MM---, createdTime=Wed Sep 13 16:40:57 CST 2023, time=2023-09-13, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2192675, encodeId=d23d21926e582, content=审稿速度:12.0<br>经验分享:2023年7月投稿<br>一审73天<br>二审(包含元旦)73天<br>临时接收到正式接收 29天<br><br>可以说很慢了,急着毕业不推荐<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e592182462, createdName=12077503m07(暂无昵称), createdTime=Tue Mar 12 01:03:15 CST 2024, time=2024-03-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185091, encodeId=6ca521850918c, content=审稿速度:1.0<br>经验分享:一篇综述原则性接收了 总体来说挺快的 23.10.23 提交 23.10.24 第一次under consideration 23.11.13 第二次under consideration 23.11.18 Decision Made 23.11.20 send author 24.1.14 修回 24.1.15 第一次under consideration 24.1.15 第二次under consideration 24.1.26 Decision Made 24.1.30 原则性接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Wed Jan 31 20:04:17 CST 2024, time=2024-01-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2150842, encodeId=10cf215084251, content=审稿速度:1.0<br>偏重的研究方向:非编码RNA与肿瘤<br>经验分享:投了小cdd一个月送审返回意见后被拒,自行补了一部分实验后转投这里 6.5 投稿 6.19 小修 7.13 补了实验返回去 7.18 原则性接收 7.20 改好格式返回 7.26 接收 7.28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2598527487, createdName=Terryzhong15, createdTime=Tue Aug 01 23:23:27 CST 2023, time=2023-08-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:Cddise转投过来的,9天decision made,不知道是什么结果,这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188846, encodeId=a2db21888463f, content=2月5号投的,当天分配编辑并Under Consideration,现在投稿17天了还没有消息,大家最近都是多久送审或者被拒的呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLv3zmjYMzwQhcQkUYuJuQtVn1K9UfSHicAAqich642LF9jozKbFliaZw0tGbw3kSTrABiaD0O5JDHXXQ/132, createdBy=215e5309360, createdName=legendaryCYP, createdTime=Fri Feb 23 10:37:35 CST 2024, time=2024-02-23, status=1, ipAttribution=上海)]
    2024-01-31 ms6000001563747786 来自江西省

    审稿速度:1.0
    经验分享:一篇综述原则性接收了 总体来说挺快的 23.10.23 提交 23.10.24 第一次under consideration 23.11.13 第二次under consideration 23.11.18 Decision Made 23.11.20 send author 24.1.14 修回 24.1.15 第一次under consideration 24.1.15 第二次under consideration 24.1.26 Decision Made 24.1.30 原则性接收

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运,编辑和审稿人一生平安!!!<br><br>Manuscript Under Consideration 11th Apr 24 05:59:46<br>Editor Assigned 10th Apr 24 04:50:35<br>Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=昨天, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2167353, encodeId=b340216e35352, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经系统凋亡及机制<br>经验分享:更新一下投稿时间线:<br>Manuscript Received: 7.3<br>Editor Assigned :7.3<br>Manuscript Under Consideration: 7.4<br>Manuscript Under Consideration: 8.31<br>Decision Made: 9.2<br>Decision Sent to Author: 9.8 (一审65天,等的急啊;要求11.1前返回)<br>Manuscript Received: 10.18<br>Editor Assigned: 10.18<br>Manuscript Under Consideration: 10.19<br>目前返回20天了,research square状态还是 Submission checks complete,编辑还没有返回审稿人手里,要怎么办呀?要催吗?二审一般多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=58, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daea8237862, createdName=ms6000000748440029, createdTime=Wed Nov 08 10:04:15 CST 2023, time=2023-11-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2100036, encodeId=1276210003694, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:请问大家,Decision sent back to author后底部有一个<br>There are action items pending. Please click on the links next to the arrows .<br>Manuscript Tasks<br> Request Appeal<br> Check Status<br>这是什么意思,通讯作者也没有收到邮件,是拒稿了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3a515544947, createdName=ms3000001031683106, createdTime=Sat Nov 12 10:28:29 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0<br>经验分享:under consideration80天了,谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157541, encodeId=1ccd215e54134, content=偏重的研究方向:细胞死亡<br>经验分享:之前投小CDD送审后被拒建议转投小小CDD。半个月后编辑将之前的审稿意见再次返回来,建议根据审稿意见修改。因为上次有一份审稿意见并不是很理想加上面临毕业,所以比较担心。有没有相同经历的朋友可以分享一下经验呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fda95570287, createdName=MM---, createdTime=Wed Sep 13 16:40:57 CST 2023, time=2023-09-13, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2192675, encodeId=d23d21926e582, content=审稿速度:12.0<br>经验分享:2023年7月投稿<br>一审73天<br>二审(包含元旦)73天<br>临时接收到正式接收 29天<br><br>可以说很慢了,急着毕业不推荐<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e592182462, createdName=12077503m07(暂无昵称), createdTime=Tue Mar 12 01:03:15 CST 2024, time=2024-03-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185091, encodeId=6ca521850918c, content=审稿速度:1.0<br>经验分享:一篇综述原则性接收了 总体来说挺快的 23.10.23 提交 23.10.24 第一次under consideration 23.11.13 第二次under consideration 23.11.18 Decision Made 23.11.20 send author 24.1.14 修回 24.1.15 第一次under consideration 24.1.15 第二次under consideration 24.1.26 Decision Made 24.1.30 原则性接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Wed Jan 31 20:04:17 CST 2024, time=2024-01-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2150842, encodeId=10cf215084251, content=审稿速度:1.0<br>偏重的研究方向:非编码RNA与肿瘤<br>经验分享:投了小cdd一个月送审返回意见后被拒,自行补了一部分实验后转投这里 6.5 投稿 6.19 小修 7.13 补了实验返回去 7.18 原则性接收 7.20 改好格式返回 7.26 接收 7.28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2598527487, createdName=Terryzhong15, createdTime=Tue Aug 01 23:23:27 CST 2023, time=2023-08-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:Cddise转投过来的,9天decision made,不知道是什么结果,这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188846, encodeId=a2db21888463f, content=2月5号投的,当天分配编辑并Under Consideration,现在投稿17天了还没有消息,大家最近都是多久送审或者被拒的呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLv3zmjYMzwQhcQkUYuJuQtVn1K9UfSHicAAqich642LF9jozKbFliaZw0tGbw3kSTrABiaD0O5JDHXXQ/132, createdBy=215e5309360, createdName=legendaryCYP, createdTime=Fri Feb 23 10:37:35 CST 2024, time=2024-02-23, status=1, ipAttribution=上海)]
    2023-08-01 Terryzhong15 来自广东省

    审稿速度:1.0
    偏重的研究方向:非编码RNA与肿瘤
    经验分享:投了小cdd一个月送审返回意见后被拒,自行补了一部分实验后转投这里 6.5 投稿 6.19 小修 7.13 补了实验返回去 7.18 原则性接收 7.20 改好格式返回 7.26 接收 7.28 proof

    6

    展开6条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运,编辑和审稿人一生平安!!!<br><br>Manuscript Under Consideration 11th Apr 24 05:59:46<br>Editor Assigned 10th Apr 24 04:50:35<br>Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=昨天, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2167353, encodeId=b340216e35352, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经系统凋亡及机制<br>经验分享:更新一下投稿时间线:<br>Manuscript Received: 7.3<br>Editor Assigned :7.3<br>Manuscript Under Consideration: 7.4<br>Manuscript Under Consideration: 8.31<br>Decision Made: 9.2<br>Decision Sent to Author: 9.8 (一审65天,等的急啊;要求11.1前返回)<br>Manuscript Received: 10.18<br>Editor Assigned: 10.18<br>Manuscript Under Consideration: 10.19<br>目前返回20天了,research square状态还是 Submission checks complete,编辑还没有返回审稿人手里,要怎么办呀?要催吗?二审一般多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=58, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daea8237862, createdName=ms6000000748440029, createdTime=Wed Nov 08 10:04:15 CST 2023, time=2023-11-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2100036, encodeId=1276210003694, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:请问大家,Decision sent back to author后底部有一个<br>There are action items pending. Please click on the links next to the arrows .<br>Manuscript Tasks<br> Request Appeal<br> Check Status<br>这是什么意思,通讯作者也没有收到邮件,是拒稿了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3a515544947, createdName=ms3000001031683106, createdTime=Sat Nov 12 10:28:29 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0<br>经验分享:under consideration80天了,谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157541, encodeId=1ccd215e54134, content=偏重的研究方向:细胞死亡<br>经验分享:之前投小CDD送审后被拒建议转投小小CDD。半个月后编辑将之前的审稿意见再次返回来,建议根据审稿意见修改。因为上次有一份审稿意见并不是很理想加上面临毕业,所以比较担心。有没有相同经历的朋友可以分享一下经验呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fda95570287, createdName=MM---, createdTime=Wed Sep 13 16:40:57 CST 2023, time=2023-09-13, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2192675, encodeId=d23d21926e582, content=审稿速度:12.0<br>经验分享:2023年7月投稿<br>一审73天<br>二审(包含元旦)73天<br>临时接收到正式接收 29天<br><br>可以说很慢了,急着毕业不推荐<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e592182462, createdName=12077503m07(暂无昵称), createdTime=Tue Mar 12 01:03:15 CST 2024, time=2024-03-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185091, encodeId=6ca521850918c, content=审稿速度:1.0<br>经验分享:一篇综述原则性接收了 总体来说挺快的 23.10.23 提交 23.10.24 第一次under consideration 23.11.13 第二次under consideration 23.11.18 Decision Made 23.11.20 send author 24.1.14 修回 24.1.15 第一次under consideration 24.1.15 第二次under consideration 24.1.26 Decision Made 24.1.30 原则性接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Wed Jan 31 20:04:17 CST 2024, time=2024-01-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2150842, encodeId=10cf215084251, content=审稿速度:1.0<br>偏重的研究方向:非编码RNA与肿瘤<br>经验分享:投了小cdd一个月送审返回意见后被拒,自行补了一部分实验后转投这里 6.5 投稿 6.19 小修 7.13 补了实验返回去 7.18 原则性接收 7.20 改好格式返回 7.26 接收 7.28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2598527487, createdName=Terryzhong15, createdTime=Tue Aug 01 23:23:27 CST 2023, time=2023-08-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:Cddise转投过来的,9天decision made,不知道是什么结果,这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188846, encodeId=a2db21888463f, content=2月5号投的,当天分配编辑并Under Consideration,现在投稿17天了还没有消息,大家最近都是多久送审或者被拒的呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLv3zmjYMzwQhcQkUYuJuQtVn1K9UfSHicAAqich642LF9jozKbFliaZw0tGbw3kSTrABiaD0O5JDHXXQ/132, createdBy=215e5309360, createdName=legendaryCYP, createdTime=Fri Feb 23 10:37:35 CST 2024, time=2024-02-23, status=1, ipAttribution=上海)]
    2024-02-19 ms5000001629270806 来自上海

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤
    经验分享:Cddise转投过来的,9天decision made,不知道是什么结果,这也太快了吧😂

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运,编辑和审稿人一生平安!!!<br><br>Manuscript Under Consideration 11th Apr 24 05:59:46<br>Editor Assigned 10th Apr 24 04:50:35<br>Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=昨天, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2167353, encodeId=b340216e35352, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经系统凋亡及机制<br>经验分享:更新一下投稿时间线:<br>Manuscript Received: 7.3<br>Editor Assigned :7.3<br>Manuscript Under Consideration: 7.4<br>Manuscript Under Consideration: 8.31<br>Decision Made: 9.2<br>Decision Sent to Author: 9.8 (一审65天,等的急啊;要求11.1前返回)<br>Manuscript Received: 10.18<br>Editor Assigned: 10.18<br>Manuscript Under Consideration: 10.19<br>目前返回20天了,research square状态还是 Submission checks complete,编辑还没有返回审稿人手里,要怎么办呀?要催吗?二审一般多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=58, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daea8237862, createdName=ms6000000748440029, createdTime=Wed Nov 08 10:04:15 CST 2023, time=2023-11-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2100036, encodeId=1276210003694, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:请问大家,Decision sent back to author后底部有一个<br>There are action items pending. Please click on the links next to the arrows .<br>Manuscript Tasks<br> Request Appeal<br> Check Status<br>这是什么意思,通讯作者也没有收到邮件,是拒稿了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3a515544947, createdName=ms3000001031683106, createdTime=Sat Nov 12 10:28:29 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0<br>经验分享:under consideration80天了,谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157541, encodeId=1ccd215e54134, content=偏重的研究方向:细胞死亡<br>经验分享:之前投小CDD送审后被拒建议转投小小CDD。半个月后编辑将之前的审稿意见再次返回来,建议根据审稿意见修改。因为上次有一份审稿意见并不是很理想加上面临毕业,所以比较担心。有没有相同经历的朋友可以分享一下经验呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fda95570287, createdName=MM---, createdTime=Wed Sep 13 16:40:57 CST 2023, time=2023-09-13, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2192675, encodeId=d23d21926e582, content=审稿速度:12.0<br>经验分享:2023年7月投稿<br>一审73天<br>二审(包含元旦)73天<br>临时接收到正式接收 29天<br><br>可以说很慢了,急着毕业不推荐<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e592182462, createdName=12077503m07(暂无昵称), createdTime=Tue Mar 12 01:03:15 CST 2024, time=2024-03-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185091, encodeId=6ca521850918c, content=审稿速度:1.0<br>经验分享:一篇综述原则性接收了 总体来说挺快的 23.10.23 提交 23.10.24 第一次under consideration 23.11.13 第二次under consideration 23.11.18 Decision Made 23.11.20 send author 24.1.14 修回 24.1.15 第一次under consideration 24.1.15 第二次under consideration 24.1.26 Decision Made 24.1.30 原则性接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Wed Jan 31 20:04:17 CST 2024, time=2024-01-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2150842, encodeId=10cf215084251, content=审稿速度:1.0<br>偏重的研究方向:非编码RNA与肿瘤<br>经验分享:投了小cdd一个月送审返回意见后被拒,自行补了一部分实验后转投这里 6.5 投稿 6.19 小修 7.13 补了实验返回去 7.18 原则性接收 7.20 改好格式返回 7.26 接收 7.28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2598527487, createdName=Terryzhong15, createdTime=Tue Aug 01 23:23:27 CST 2023, time=2023-08-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:Cddise转投过来的,9天decision made,不知道是什么结果,这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188846, encodeId=a2db21888463f, content=2月5号投的,当天分配编辑并Under Consideration,现在投稿17天了还没有消息,大家最近都是多久送审或者被拒的呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLv3zmjYMzwQhcQkUYuJuQtVn1K9UfSHicAAqich642LF9jozKbFliaZw0tGbw3kSTrABiaD0O5JDHXXQ/132, createdBy=215e5309360, createdName=legendaryCYP, createdTime=Fri Feb 23 10:37:35 CST 2024, time=2024-02-23, status=1, ipAttribution=上海)]
    2024-02-23 legendaryCYP 来自上海

    2月5号投的,当天分配编辑并Under Consideration,现在投稿17天了还没有消息,大家最近都是多久送审或者被拒的呀?

    2

    展开2条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分